After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
AMRX belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Amneal Pharmaceuticals Inc is $2.50B. A total of 1.45 million shares were traded on the day, compared to an average of 1.05M shares.
In the most recent transaction, Patel Gautam sold 17,410 shares of AMRX for 8.01 per share on Jan 02 ’25. After the transaction, the Director now owns 2,031,476 company shares. In a previous transaction on Jan 02 ’25, Gautam J Patel bought 320,000 shares at 8.00 per share.
Among the insiders who sold shares, Kiely John disposed of 17,058 shares on Nov 22 ’24 at a per-share price of $8.38. This resulted in the Director holding 267,175 shares of AMRX after the transaction. In another insider transaction, Autor Deborah M. sold 33,229 shares at $8.34 per share on Nov 22 ’24. Company shares held by the Director now total 53,402.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, AMRX has a high of $9.48 and a low of $5.01.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. AMRX’s latest balance sheet shows that the firm has $247.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.88B in debt and $677.24M in liabilities at the time. Its Book Value Per Share was -$0.30, while its Total Shareholder’s Equity was $366.97M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRX is Buy with a score of 4.60.
